Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc. (EMMA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EMMA · as of Jun 9, 2026
Key Statistics
Explore Emmaus Life Sciences, Inc. Data
emma stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
emma competitorsEMMA
BPTH
HXBM
NPHC
NRXCF
ORGSStock Performance
Full HistoryAbout Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical enterprise dedicated to the discovery, development, commercialization, and sale of treatments and therapies, primarily addressing rar…
what is emmaus life sciences, inc. · emma stock overview · emmaus life sciences, inc. company profile · who is emmaus life sciences, inc. ceo · emma OTC · emmaus life sciences, inc. headquarters · emmaus life sciences, inc. business segments
About Stock Overview & Key Data
Emmaus Life Sciences, Inc. (EMMA) is a Healthcare company in the Biotechnology industry, listed on OTC since May 9, 2000. As of the latest trading session, EMMA stock price is $0.01, with a market capitalization of $673,807. The stock has returned -41.46% over the past 12 months and -26.15% year-to-date.
In fiscal year 2025, Emmaus Life Sciences, Inc. reported revenue of $12.5M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Emmaus Life Sciences, Inc. (EMMA) stock price is $0.01. The stock is traded on OTC under the ticker symbol EMMA. The 52-week range is $0.01 – $0.02.